Bayer has patented a fluid injector system that employs a flow rate algorithm to monitor and adjust fluid delivery. The system calculates actual flow rates based on pressure changes, identifies deviations from programmed rates, and compensates for these discrepancies in subsequent delivery intervals during medical procedures. GlobalData’s report on Bayer gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Bayer, Peptide pharmacophores was a key innovation area identified from patents. Bayer's grant share as of July 2024 was 59%. Grant share is based on the ratio of number of grants to total number of patents.
Fluid injector system for accurate flow rate delivery
The patent US12070577B2 describes a fluid injector system designed for administering fluids to patients with enhanced accuracy and adaptability. The system includes a memory component that stores a programmed flow rate and a maximum allowable deviation for fluid delivery. It features at least one sensor to measure the pressure of the fluid, which is generated by a drive component during the delivery process. A control device, equipped with a processor, is responsible for determining the actual flow rate based on pressure changes over specified time intervals, calculating deviations from the programmed flow rate, and adjusting the flow rate for subsequent intervals accordingly. This iterative process aims to maintain precise fluid delivery throughout the procedure.
Additionally, the system incorporates a mechanism for flow rate correction, which compares the actual flow rate deviation to the maximum allowable deviation. If the deviation exceeds this threshold, the correction is set to the maximum allowable deviation. The system can also utilize machine learning models to optimize fluid delivery based on real-time data. The method outlined in the patent emphasizes continuous monitoring and adjustment of the flow rate, ensuring that the fluid is delivered at the newly programmed rate in subsequent intervals. This innovative approach aims to enhance the reliability and effectiveness of fluid administration in medical settings.
To know more about GlobalData’s detailed insights on Bayer, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
